Italy Preclinical Imaging Market Size & Outlook, 2026-2033
Global Report
Related Markets
Italy preclinical imaging market highlights
- The Italy preclinical imaging market generated a revenue of USD 33.5 million in 2025 and is expected to reach USD 51.0 million by 2033.
- The Italy market is expected to grow at a CAGR of 5.4% from 2026 to 2033.
- In terms of segment, modality was the largest revenue generating type in 2025.
- Service is the most lucrative type segment registering the fastest growth during the forecast period.
Preclinical imaging market data book summary
| Market revenue in 2025 | USD 33.5 million |
| Market revenue in 2033 | USD 51.0 million |
| Growth rate | 5.4% (CAGR from 2026 to 2033) |
| Largest segment | Modality |
| Fastest growing segment | Service |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modality, Reagent, Service |
| Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
Other key industry trends
- In terms of revenue, Italy accounted for 3.2% of the preclinical imaging market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany preclinical imaging market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 92.2 million by 2033.
The government of Italy is the primary purchaser of medical equipment in the country. Public hospitals account for around 75% of sales of medical devices, while the remaining 25% of sales are made to the private sector. Italy's healthcare system is a regionally based national health service that provides universal coverage, largely free of charge at the point of delivery.
Italy's preclinical imaging market is expanding, and there are numerous opportunities for U.S. companies. Surgical procedure equipment, including preclinical imaging devices, are among the best avenues for growth in the country.
The development of novel in vivo imaging agents, such as contrast agents and radiotracers, is expanding the capabilities of preclinical imaging in Italy. These agents are used to enhance the visibility of specific biological targets or processes, enabling researchers to obtain more precise and detailed images. Therefore, such advancements are expected to fuel market growth during the forecast period.
No credit card required*
Publish Date: Jan 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Preclinical Imaging Market Scope
Preclinical Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Siemens AG | View profile | 321,000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | www.siemens.com |
| GE Aerospace | View profile | 125,000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | www.geaerospace.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Rigaku | View profile | 501-1000 | Akishima, Tokyo, Japan, Asia | japan.rigaku.com/ja |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Mediso Medical Imaging Systems | View profile | 251-500 | Budapest, Budapest, Hungary, Europe | mediso.com/ |
| TriFoil Imaging | View profile | 11-50 | Chatsworth, California, United States, North America | www.trifoilimaging.com |
| MR Solutions | View profile | 101-250 | Guildford, Surrey, United Kingdom, Europe | www.mrsolutions.com/ |
Italy Preclinical Imaging Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Preclinical Imaging Market Outlook will help companies and investors design strategic landscapes.
Modality was the largest segment with a revenue share of 71.64% in 2025.
Horizon Databook has segmented the Italy preclinical imaging market based on modality, reagent, service covering the revenue growth of each sub-segment from 2021 to 2033.
The government of Italy is the primary purchaser of medical equipment in the country. Public hospitals account for around 75% of sales of medical devices, while the remaining 25% of sales are made to the private sector. Italy's healthcare system is a regionally based national health service that provides universal coverage, largely free of charge at the point of delivery.
Italy's preclinical imaging market is expanding, and there are numerous opportunities for U.S. companies. Surgical procedure equipment, including preclinical imaging devices, are among the best avenues for growth in the country.
The development of novel in vivo imaging agents, such as contrast agents and radiotracers, is expanding the capabilities of preclinical imaging in Italy. These agents are used to enhance the visibility of specific biological targets or processes, enabling researchers to obtain more precise and detailed images. Therefore, such advancements are expected to fuel market growth during the forecast period.
- Italy Preclinical Imaging Market Type Outlook (Revenue, USD Million , 2021-2033)
- Modality
- Reagent
- Service
- Italy Preclinical Imaging Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery & Development
- Toxicology & Pharmacokinetics Studies
- Basic & Translational Research
- Disease Mechanism & Pathophysiology Studies
- Biomarker & Imaging Agent Validation
- Others Application
- Italy Preclinical Imaging Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others End Use
Reasons to subscribe to Preclinical Imaging Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Preclinical Imaging Market Outlook databook
- Our clientele includes a mix of Preclinical Imaging Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Preclinical Imaging Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Preclinical Imaging Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Italy Preclinical Imaging Market, 2021-2033 (US$M)
Italy Type - Preclinical Imaging Market Statistics, 2025 - 2033 (US$M)
